Table 3.
Variable | Univariate | Model I a | Model II b | |||
---|---|---|---|---|---|---|
OR (95%CI) | P-value | OR (95%CI) | P-value | OR (95%CI) | P-value | |
METs quartiles | ||||||
Q1 | 1 | 1 | 1 | |||
Q2 | 0.618 (0.614–0.621) | <0.001* | 0.636 (0.632–0.639) | <0.001* | 0.688 (0.684–0.692) | <0.001* |
Q3 | 0.451 (0.449–0.454) | <0.001* | 0.437 (0.434–0.439) | <0.001* | 0.463 (0.460–0.466) | <0.001* |
Q4 | 0.597 (0.594–0.6) | <0.001* | 0.735 (0.731–0.739) | <0.001* | 0.816 (0.812–0.821) | <0.001* |
P for trend | <0.001* | <0.001* | <0.001* |
Adjust for age, sex, race, education level, and marital status.
Adjust for age, sex, race, education level, marital status, family PIR, smoking, drinking alcohol, BMI, total cholesterol, and fasting plasma glucose.
PAD, peripheral artery disease; OR, odds ratio; OR <1.0 means lower likelihood for PAD.
CI, confidence interval; PIR, poverty-to-income ratio; BMI, body mass index.
METs increases from Q1 to Q4.
Considered statistically significant p < 0.05.